The transaction was valued at approximately $947,700.
The Xometry stock price has handily outperformed the S&P 500 over the past year.
The activity was structured as an exercise-and-sell transaction, where 10,000 options were exercised at $4.46 per share and immediately sold.
Katharine Weymouth, a Director at Xometry (NASDAQ:XMTR), reported a sale of 10,000 shares of Class A common stock, according to a recent SEC Form 4 filing.
| Metric | Value |
|---|---|
| Transaction value | $947,700 |
| Shares sold | 10,000 |
| Post-transaction shares (directly held) | 35,345 |
| Post-transaction value | $3.2 million |
Transaction value based on SEC Form 4 weighted average sale price ($94.77); post-transaction value based on Aug. 31, 2026, market close ($92.69).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-28) | $94.11 |
| Market Capitalization | $5.5 billion |
| Revenue (TTM) | $807.5 million |
| Net Income (TTM) | -$30.8 million |
Xometry is a leading digital marketplace in the industrial distribution and custom manufacturing sectors, with a market capitalization of $5.5 billion and TTM revenue of $807.5 million. The company has demonstrated significant market momentum, with its stock appreciating 87.3% over the past twelve months, reflecting investor confidence in the digital transformation of manufacturing supply chains. Xometry's competitive advantage derives from its technology-driven approach to manufacturing procurement, which reduces sourcing complexity and enables customers to access a global network of vetted manufacturing partners through a unified digital platform.
The transaction by Weymouth appears largely routine, as it involved exercising options without disrupting overall holdings. The insider still holds 35,345 shares, showing continued alignment with the company. Also, even if this were a direct stock sale without options, it would still be understandable for an insider to sell shares, given how well Xometry's stock price has performed. As of this writing, over the past 12 months, Xometry shares have climbed 86.8%. In comparison, the S&P 500 is up 15.7%. With all that context, this doesn't appear to be anything shareholders should worry about, as it doesn't signal a loss of confidence in the company.
Given what happened to Xometry's stock price over the past 12 months, analysts still generally see upside for the company over the next year. According to CNN, the median one-year price target from the 12 analysts covering the stock is $110. From the price as of this writing, $96.06, that would represent a potential 14.5% gain. The highest target, $126, would represent a 31.1% gain, while the lowest target, $95, would represent a 1.1% loss.
Before you buy stock in Xometry, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Xometry wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $412,074!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,314,319!*
Now, it’s worth noting Stock Advisor’s total average return is 932% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of September 17, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Xometry. The Motley Fool has a disclosure policy.